Article info
Letter
Anti-tumour necrosis factor α therapy modulates ghrelin in patients with severe rheumatoid arthritis
- Miguel A Gonzalez-Gay, Rheumatology Division, Hospital Xeral-Calde, c) Dr Ochoa s/n, 27004, Lugo, Spain; miguelaggay{at}hotmail.com
Citation
Anti-tumour necrosis factor α therapy modulates ghrelin in patients with severe rheumatoid arthritis
Publication history
- Accepted February 8, 2008
- First published October 14, 2008.
Online issue publication
April 13, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2008 BMJ Publishing Group and European League Against Rheumatism